Panayiotis Vasiloudes, MD
Dermatology · Tampa, FLNPI 1134129505
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 44.9% of the total. Reporting peaked in 2019 at $7,632 and has fallen 92.2% since, to $594 in 2025.
Across 127 payments — averaging $103.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$6K
- Merz North America, Inc.$3K
- AbbVie$3K
- Galderma Laboratories, L.p.$980
- Pfizer$163
- Genentech USA, Inc.$129
- plus $484 from 10 others
Across 55 payments — averaging $3513.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$172K
- Endo Pharmaceuticals Inc.$9K
- Incyte Corporation$7K
- Janssen Research & Development, LLC$4K
- Merck$1K
What the payments were for
- Consulting fees$5,17540%
- Speaking & faculty fees$2,03816%
- Travel & lodging$3062%
- Food & beverage$5,57543%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $5,880 |
| Merz North America, Inc. | 30 | $2,873 |
| AbbVie(2 entities) | 35 | $2,584 |
| Galderma Laboratories, L.p. | 23 | $980 |
| Pfizer | 6 | $163 |
| Genentech USA, Inc. | 2 | $129 |
| Lilly USA, LLC | 1 | $125 |
| Johnson & Johnson | 5 | $88 |
| E.r. Squibb & Sons, L.L.C. | 4 | $86 |
| Strata Skin Sciences, Inc. | 5 | $32 |
| Sanofi | 1 | $32 |
| Kerecis Limited | 3 | $27 |
| Almirall LLC | 1 | $25 |
| Dermavant Sciences, Inc. | 1 | $24 |
| Amgen | 1 | $24 |
| LEO Pharma Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,094 in reported general payments places this provider in the 80th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 88 | $5,616 |
| Cyclosporine ModifiedCyclosporine, Modified | 38 | $4,070 |
| Mycophenolate Mofetil | 37 | $2,101 |
| Triamcinolone Acetonide | 131 | $1,794 |
| Ketoconazole | 38 | $510 |
| Metronidazole | 15 | $501 |
| Ammonium Lactate | 23 | $461 |
| Doxycycline Hyclate | 35 | $406 |
| Fluconazole | 16 | $299 |
| Minoxidil | 25 | $209 |
| Mupirocin | 28 | $193 |
| Prednisone | 28 | $155 |
| Terbinafine Hcl | 27 | $154 |
| ValacyclovirValacyclovir Hcl | 16 | $130 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tampa
- Seth FormanTampa$407K
- Asha ShahTampa$332K
- Nishit PatelTampa$111K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.